risperidone has been researched along with Hypomenorrhea in 7 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence of hyperprolactinemia during treatment with conventional antipsychotic drugs or risperidone is under-recognized and requires further investigation." | 9.10 | Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. ( Gilmore, JA; Halbreich, UM; Kinon, BJ; Liu, H, 2003) |
| "This study was conducted to prospectively examine the effect of switching from risperidone to olanzapine on female schizophrenia patients who experienced menstrual disturbances, galactorrhea, and/or sexual dysfunction." | 9.10 | Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. ( Bahk, WM; Chae, JH; Dickson, RA; Jun, TY; Kim, DJ; Kim, KS; Pae, CU, 2002) |
| "The prevalence of hyperprolactinemia during treatment with conventional antipsychotic drugs or risperidone is under-recognized and requires further investigation." | 5.10 | Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. ( Gilmore, JA; Halbreich, UM; Kinon, BJ; Liu, H, 2003) |
| "This study was conducted to prospectively examine the effect of switching from risperidone to olanzapine on female schizophrenia patients who experienced menstrual disturbances, galactorrhea, and/or sexual dysfunction." | 5.10 | Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. ( Bahk, WM; Chae, JH; Dickson, RA; Jun, TY; Kim, DJ; Kim, KS; Pae, CU, 2002) |
| "Cyclical menstrual psychosis is an uncommon, generally a self-limiting mental illness that occurs only in females." | 2.58 | An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature. ( Birur, B; Cohen, AW; Nagaraja, S; Thippaiah, SM, 2018) |
| " In addition, adverse events were also evaluated." | 1.34 | [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. ( Agoston, T; István, S; Tamás, T; Zoltán, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thippaiah, SM | 1 |
| Nagaraja, S | 1 |
| Birur, B | 1 |
| Cohen, AW | 1 |
| Findling, RL | 1 |
| Daneman, D | 1 |
| Emsley, R | 1 |
| Oosthuizen, P | 1 |
| Koen, L | 1 |
| Niehaus, DJ | 1 |
| Medori, R | 1 |
| Rabinowitz, J | 1 |
| Canuso, CM | 1 |
| Goldstein, JM | 1 |
| Wojcik, J | 1 |
| Dawson, R | 1 |
| Brandman, D | 1 |
| Klibanski, A | 1 |
| Schildkraut, JJ | 1 |
| Green, AI | 1 |
| Kinon, BJ | 1 |
| Gilmore, JA | 1 |
| Liu, H | 1 |
| Halbreich, UM | 1 |
| István, S | 1 |
| Agoston, T | 1 |
| Tamás, T | 1 |
| Zoltán, J | 1 |
| Kim, KS | 1 |
| Pae, CU | 1 |
| Chae, JH | 1 |
| Bahk, WM | 1 |
| Jun, TY | 1 |
| Kim, DJ | 1 |
| Dickson, RA | 1 |
1 review available for risperidone and Hypomenorrhea
| Article | Year |
|---|---|
An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature.
Topics: Adult; Female; Humans; Menstruation Disturbances; Psychotic Disorders; Risperidone; Tranquilizing Ag | 2018 |
2 trials available for risperidone and Hypomenorrhea
| Article | Year |
|---|---|
Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Estrogens; Female; | 2003 |
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
Topics: Adolescent; Adult; Amenorrhea; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Female | 2002 |
4 other studies available for risperidone and Hypomenorrhea
| Article | Year |
|---|---|
Prolactin Levels During Long-Term Risperidone Treatment in Children and Adolescents: a reanalysis of data.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Data I | 2016 |
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Delayed-Action Preparations; Double-B | 2008 |
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Estradiol; Female; Humans; Hyperprolactinem | 2002 |
[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
Topics: Adult; Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzo | 2007 |